ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Xultophy®:Novo Nordisk Pharma AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
A10AE56 - Insulin Degludec and LiraglutideATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A10 - Drugs Used in Diabetes
 
A10A - Insulins and Analogues

This group comprises both human - and animal insulins.
Insulin preparations are classified at 4 different 4th levels, according to onset and duration of action. Each 4th level is differentiated in 5th levels according to origin of insulin.
Products consisting of, e.g. beef and pork insulin, are classified as combinations (30-levels) at each 4th level according to onset and duration of action.

The DDD for insulins is 40 units.

A10AE - Insulins and Analogues for Injection, Long-Acting
 
A10AE56 - Insulin Degludec and Liraglutide
StärkeAdm.RouteNote
 PRefers to insulin degludec
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home